4D Molecular Therapeutics, Inc. - Common Stock — 재무제표 (NASDAQ:FDMT) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 288.33 M353.49 M261.85 M339.89 M560.38 M566.71 M 총 부채 31.94 M34.38 M30.51 M32.06 M49.78 M61.05 M 자본금 총액 256.39 M319.11 M231.34 M307.83 M510.61 M505.66 M 총 부채 및 주주자본 288.33 M353.49 M261.85 M339.89 M560.38 M566.71 M 총부채 —————— 순부채 ——————

뉴스

4D Molecular Therapeutics, Inc. (FDMT) Presents at Bank of America Global Healthcare Conference 2026 Transcript

4D Molecular Therapeutics, Inc. (FDMT) Reports Q1 Loss, Lags Revenue Estimates

Aclaris Therapeutics (ACRS) Reports Q1 Loss, Beats Revenue Estimates

electroCore (ECOR) Moves 7.1% Higher: Will This Strength Last?

4D Molecular Therapeutics, Inc. (FDMT) Q4 Earnings and Revenues Beat Estimates

4D Molecular Therapeutics, Inc. (FDMT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

4D Molecular Therapeutics, Inc. (FDMT) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:FDMT) 2026-01-19

RBC 캐피털, 4D Molecular에 ’아웃퍼폼’ 투자의견 재확인

RBC Capital reiterates Outperform rating on 4D Molecular stock at $32

Ashoo Gupta, FDMT 주식 3.3천 달러 상당 매도

Ashoo Gupta of 4D Molecular Therapeutics sells $3.3k in FDMT stock

4D Molecular Therapeutics: Jury Still Out On CF Gene Therapy After Dense Data Drop (NASDAQ:FDMT)